会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Superoxide dismutase derivatives, a method of producing the same and
medicinal uses of the same
    • 超氧化物歧化酶衍生物,其生产方法及其药物用途
    • US5137820A
    • 1992-08-11
    • US199809
    • 1988-05-27
    • Hiroshi MaedaFujio SuzukiTatsuya Oda
    • Hiroshi MaedaFujio SuzukiTatsuya Oda
    • A61K38/44C12N9/02
    • C12N9/0089A61K38/446Y10S530/815
    • The invention provides a superoxide dismutase derivative of the general formula[SOD][Z].sub.nwherein [SOD] represents a superoxide dismutase having 1 to 22 or 24 groups each derived from an amino group by removal of one hydrogen atom in lieu of amino groups; [Z] represents a monovalent copolymer group, constituting units of which are a group of the formula ##STR1## wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4 each represents a hydrogen atom or a residue derived by removal of a hydroxyl group from an alkanol of 1 to 8 carbon atoms, an ethylene glycol monoalkyl ether containing an alkyl moiety of 1 to 4 carbon atoms or a glycerin dialkyl ether containing alkyl moieties of 1 to 4 carbon atoms, provided that either R.sup.1 or R.sup.2 and either R.sup.3 or R.sup.4 each represents a hydrogen atom, and a residue derived from the group of the above-mentioned formula by removal of OR.sup.1, OR.sup.2, OR.sup.3 or OR.sup.4 group from one of its COOR.sup.1, COOR.sup.2, COOR.sup.3 and COOR.sup.4 groups (where the bond on the carbon atom of the carbonyl group is attached to [SOD]), said monovalent copolymer group having an average molecular weight of 500 to 200,000; and n represents an integer of 1 to 22 or 24 corresponding to the number of said groups each derived from an amino group by removal of one hydrogen atom in said [SOD], or a pharmaceutically acceptable salt thereof. There also is provided a method for producing the above derivative and salt. The invention is further directed to medicinal uses and pharmaceutical compositions for oral administration.
    • 2. 发明授权
    • Superoxide dismutase derivatives, a method of producing the same and
medicinal uses of the same
    • 超氧化物歧化酶衍生物,其制备方法及其药用用途
    • US5180582A
    • 1993-01-19
    • US836861
    • 1992-02-19
    • Hiroshi MaedaFujio SuzukiTatsuya Oda
    • Hiroshi MaedaFujio SuzukiTatsuya Oda
    • A61K38/44C12N9/02
    • C12N9/0089A61K38/446
    • The invention provides a superoxide dismutase derivative of the general formula[SOD][Z]wherein [SOD] represents a superoxide dismutase having 1 to 22 or 24 groups each derived from an amino groups by removal of one hydrogen atom in lieu of amino groups; [Z] represents a monovalent copolymer group, constituting units of which are a group of the formula ##STR1## wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4 each represents a hydrogen atom or a residue derived by a removal of a hydroxyl group from an alkanol of 1 to 8 carbon atoms, an ethylene glycol monoalkyl ether containing an alkyl moiety of 1 to 4 carbon atoms or a glycerin dialkyl ether containing alkyl moieties of 1 to 4 carbon atoms, provided that either R.sup.1 or R.sup.2 and either R.sup.3 or R.sup.4 each represents a hydrogen atom, and a residue derived from the group of the above-mentioned formula by removal of OR.sup.1, OR.sup.2, OR.sup.3 or OR.sup.4 group from one of its COOR.sup.1, COOR.sup.2, COOR.sup.3 and COOR.sup.4 groups (where the bond on the carbon atom of the carbonyl group is attached to [SOD]), said monovalent copolymer group having an average molecular weight of 500 to 200,000; and n represents an integer of 1 to 22 or 24 corresponding to the number of said groups each derived from an amino group by removal of one hydrogen atom in said [SOD], or a pharmaceutically acceptable salt thereof. There also is provided a method for producing the above derivative and salt. The invention is further directed to medicinal uses and pharmaceutical compositions for oral administration.
    • 本发明提供了一种通式[SOD] [Z]的超氧化物歧化酶衍生物,其中[SOD]代表通过除去一个氢原子代替氨基,每个衍生自氨基的具有1至22个或24个基团的超氧化物歧化酶; [Z]表示单价共聚物基团,其构成单元为式“IMAGE”的基团,其中R 1,R 2,R 3和R 4各自表示氢原子或通过从烷醇中除去羟基而得到的残基 1至8个碳原子的烷基部分,含有1至4个碳原子的烷基部分的乙二醇单烷基醚或含有1至4个碳原子的烷基部分的甘油二烷基醚,条件是R 1或R 2以及R 3或R 4各自表示 氢原子和衍生自上述式的基团的残基,通过从其COOR1,COOR2,COOR3和COOR4基团之一除去OR1,OR2,OR3或OR4基团(其中羰基的碳原子上的键 所述单价共聚物基团的平均分子量为500〜200,000; n表示通过除去所述[SOD]中的一个氢原子而衍生自氨基的所述基团的数目的1-22或24的整数或其药学上可接受的盐。 还提供了制备上述衍生物和盐的方法。 本发明进一步涉及药物用途和用于口服给药的药物组合物。
    • 8. 发明授权
    • Vehicle seat
    • 车座
    • US06676218B2
    • 2004-01-13
    • US10053829
    • 2002-01-22
    • Etsunori FujitaSeiji KawsakiSeiji SesakiTatsuya OdaYuji Ikeda
    • Etsunori FujitaSeiji KawsakiSeiji SesakiTatsuya OdaYuji Ikeda
    • A47C702
    • B60N2/70B60N2/5891D04B21/16D10B2403/0213
    • An object of the present invention is to minimize the dependency of the vibration characteristic exhibited by the sheet-shaped supporting member supported by the metal springs on the added load. In a plurality of metal springs 41 to 44 supporting a sheet-shaped supporting member 30, a third metal spring 43 provided on the position to support the vicinity of the greater trochanter of the seated person is provided in a manner that an engagement portion with a frame member is positioned lower than the engagement portion with the sheet-shaped supporting member 30 when no load is applied. Accordingly, the feeling of something foreign created by such a third metal spring 43 can be reduced, and within a predetermined range of the added load, the third metal spring does not work functionally because respective engagement portions 43a and 43b take their positional relationship to be substantially horizontal in a static seating state, while it works functionally when the added load exceeds the above-described range. As a result, difference in added load can be reduced.
    • 本发明的目的是最小化由金属弹簧支撑的片状支撑构件所显示的振动特性对所加载荷的依赖性。 在支撑片状支撑构件30的多个金属弹簧41〜44中,设置在支撑就座者的大转子附近的位置的第三金属弹簧43设置成具有 当没有施加负载时,框架构件定位成低于与片状支撑构件30的接合部分。 因此,可以减少由这种第三金属弹簧43产生的异物的感觉,并且在附加载荷的预定范围内,第三金属弹簧在功能上不起作用,因为各个接合部43a和43b的位置关系为 基本上水平地处于静态就座状态,而当加载负载超过上述范围时,其功能正常。 结果,可以减少加载负载的差异。